No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales

Caroline L. Trotter*, Mary E. Ramsay, Stephen Gray, Andrew Fox, Edward Kaczmarski

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

43 Citations (Scopus)
Original languageEnglish
Pages (from-to)616-617
Number of pages2
JournalThe Lancet Infectious Diseases
Volume6
Issue number10
DOIs
Publication statusPublished - Oct 2006

Bibliographical note

Funding Information:
The Immunisation Department and the Meningococcal Reference Unit of the Health Protection Agency have received grants from vaccine manufacturers in accordance with our code of conduct ( http://www.hpa.org.uk/infections/about/dir/psp.pdf ). MER, EK and SG have received support from vaccine manufacturers to attend conferences and meetings. CLT and AF have no conflicts of interest to declare. This work was funded as part of the core activities of the Health Protection Agency; no additional funding was required.

Cite this